ARTICLE;
CONTROLLED STUDY;
DRUG DOSE;
DRUG EFFICACY;
DRUG MEGADOSE;
DRUG RESEARCH;
LOW DRUG DOSE;
METHODOLOGY;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
SAMPLE SIZE;
SIMULATION;
THEORETICAL STUDY;
CLINICAL TRIALS, PHASE II AS TOPIC;
DATA INTERPRETATION, STATISTICAL;
DOSE-RESPONSE RELATIONSHIP, DRUG;
HUMANS;
MODELS, STATISTICAL;
PHARMACEUTICAL PREPARATIONS;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
RESEARCH DESIGN;
SAMPLE SIZE;
TIME FACTORS;
New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada
Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000;92:205-16
Sequential nonparametrics and semiparametrics: Theory, implementation and applications to clinical trials. Beyond parametrics in interdisciplinary research
Lai TL, su Z. Sequential nonparametrics and semiparametrics: theory, implementation and applications to clinical trials. Beyond parametrics in interdisciplinary research. IMS Monograph Series 2007;1:332-49
Bias correction and confidence intervals following sequential tests. Nonparametric inference and probability with applications to science
Lai TL, su Z, Chuang CS. Bias correction and confidence intervals following sequential tests. Nonparametric inference and probability with applications to science. IMS Lecture Notes - Monograph Series 2006;50:44-57
